Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v7-FR
Language French French
Date Updated 2018-07-05 2018-07-05
Drug Identification Number 02245648 02245648
Brand name MYLAN-CIPROFLOXACIN MYLAN-CIPROFLOXACIN
Common or Proper name CIPROFLOXACIN CIPROFLOXACIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BT, 500 BT 100 BT, 500 BT
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03 2018-07-03
Actual start date 2018-07-03 2018-07-03
Estimated end date Unknown Unknown
Actual end date 2018-07-03 2018-07-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Discontinued in ID 51283 Discontinued in ID 51283
Health Canada comments